Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Furuya

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Journal of Translational Medicine|October 9, 2016
A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohortSteve Goodison, Osamu Ogawa, Yoshiyuki Matsui, et al.
Diagnostics (Basel, Switzerland)|January 8, 2020
Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial CarcinomaHideki Furuya, Owen T M Chan, Kanani Hokutan, et al.
Oncotarget|December 17, 2017
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patientsOwen T M Chan, Hideki Furuya, Ian Pagano, et al.
International Journal of Molecular Sciences|January 11, 2024
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder CancerTouseef Ahmad Qureshi, Xingyu Chen, Yibin Xie, et al.
Experimental and Molecular Pathology|March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerToru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
Pharmacology & Therapeutics|December 22, 2019
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic targetOlga A Sukocheva, Hideki Furuya, Mei Li Ng, et al.
Journal of Translational Medicine|February 7, 2020
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse modelHideki Furuya, Kazukuni Hayashi, Yoshiko Shimizu, et al.
Nature Communications|August 13, 2021
An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancerKenneth H Gouin, Nathan Ing, Jasmine T Plummer, et al.
Journal of Translational Medicine|March 17, 2017
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse modelAgata Szymiczek, Sandra Pastorino, David Larson, et al.
The Journal of Urology|October 3, 2025
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial CarcinomaKazutoshi Fujita, Makito Miyake, Mamoru Hashimoto, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of Translational Medicine|October 9, 2016
A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohortSteve Goodison, Osamu Ogawa, Yoshiyuki Matsui, et al.
Diagnostics (Basel, Switzerland)|January 8, 2020
Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial CarcinomaHideki Furuya, Owen T M Chan, Kanani Hokutan, et al.
Oncotarget|December 17, 2017
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patientsOwen T M Chan, Hideki Furuya, Ian Pagano, et al.
International Journal of Molecular Sciences|January 11, 2024
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder CancerTouseef Ahmad Qureshi, Xingyu Chen, Yibin Xie, et al.
Experimental and Molecular Pathology|March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerToru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
Pharmacology & Therapeutics|December 22, 2019
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic targetOlga A Sukocheva, Hideki Furuya, Mei Li Ng, et al.
Journal of Translational Medicine|February 7, 2020
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse modelHideki Furuya, Kazukuni Hayashi, Yoshiko Shimizu, et al.
Nature Communications|August 13, 2021
An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancerKenneth H Gouin, Nathan Ing, Jasmine T Plummer, et al.
Journal of Translational Medicine|March 17, 2017
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse modelAgata Szymiczek, Sandra Pastorino, David Larson, et al.
The Journal of Urology|October 3, 2025
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial CarcinomaKazutoshi Fujita, Makito Miyake, Mamoru Hashimoto, et al.
Pageof 8